Silence Therapeutics | SLN - Operating Profit

Stock Price
4.81
Daily Change
0.51 11.86%
Monthly
-18.89%
Yearly
-20.50%
Q1 Forecast
4.72

Silence Therapeutics reported $-22.54M in Operating Profit for its fiscal quarter ending in September of 2024.





Operating Profit Change Date
AstraZeneca USD -1.5B 5.01B Sep/2025
Autolus Therapeutics Ltd USD -82.61M 17.37M Jun/2025
Hikma Pharmaceutical USD 187M 95M Jun/2025
Novartis USD 4.5B 363M Sep/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Silence Therapeutics USD -22.54M 4.21M Sep/2024